Literature DB >> 3525862

Current status of chemotherapy sensitivity testing for urological malignancies.

J L Chin, H K Slocum, M A Bulbul, Y M Rustum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3525862     DOI： 10.1016/s0022-5347(17)44971-8

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Glucose consumption end point in primary histoculture indicates recovery of human tumors from drug treatment.

Authors:  S G Chang; H K Slocum; K Tòth; R M Hoffman; S D Perrapato; R P Huben; Y Rustum
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  Clonal growth of bladder cancer cells in a double layer soft agar assay: needles addition of multiple culture supplements.

Authors:  K Lee; P Smith; G H Weiss; A T Cockett
Journal:  Urol Res       Date:  1990

3.  Growth characteristics of early passage cell lines compared with established TCC bladder lines.

Authors:  V H Nargund; I K Barker; L Coombs; G M Flannigan; P A Stewart; S M Crawford
Journal:  Urol Res       Date:  1994

4.  Comparative study of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and tritiated thymidine in a chemosensitivity test using collagen gel matrix.

Authors:  M Egawa; H Hisazumi; T Uchibayashi; M Tanaka; T Sasaki
Journal:  Urol Res       Date:  1993-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.